Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing the Safety and Efficacy of EDUG-guided Tunnel PICC With Conventional PICC in Immunocompromised Patients: a Multicenter, Prospective, Randomized Controlled Clinical Study

NCT05621473 is registered in ClinicalTrials.gov with Shandong Branden Med.Device Co.,Ltd as lead sponsor.

NCT NCT05621473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05621473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing the Safety and Efficacy of EDUG-guided Tunnel PICC With Conventional PICC in Immunocompromised Patients: a Multicenter, Prospective, Randomized Controlled Clinical Study
Lead sponsor
Shandong Branden Med.Device Co.,Ltd
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2022
Completion date
December 31, 2023
Enrollment
420 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

the incidence of picc-related complications